Issue 127 • February 2023 Tracking the ups and downs of pharma deals Regulation starts to catch up with AI in pharma High hopes for mRNA anti-cancer vaccines In association with CRISPR gene therapies cut through in 2023 The first approval decision for a CRISPR gene therapy in 2023 sets expectations for things to come In association with Issue 127 Brought to you by 01/20/2023 12:07:36